Product Images Trulicity
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 47 images provide visual information about the product associated with Trulicity NDC 50090-3483 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text appears to be describing the different parts of a medical injection device. It includes labels for a "Top," "Button," "LockRing," "Indicator," "Medicine," "Bottom," "Needle," "End," and "Base Cap." The text seems to be explaining how to use the device, but without additional context or images, it is difficult to provide more specific information.*
The text is describing the parts of an injection pen. It includes labels for the top and bottom pieces, a lock ring and indicator, and a button to dispense the medicine. There is also a needle and end cap mentioned.*
This is a simple instruction about administering an injection. Once the gray plunger is visible, it signals the completion of the injection.*
The text seems to be a partial description of a device or product. It mentions a "Top B MR injection Button" and a "LockRing" with an indicator for locking and unlocking. Additionally, there is a mention of "Medicine", which possibly indicates that the product may be used in the medical field. However, the context and purpose of the device cannot be determined with this limited information.*
This text provides instructions for administering an injection. Specifically, it indicates that the injection process is complete when the gray plunger is visible. The text does not provide any further information concerning the type of injection or its purpose.*
This is a description of the Trulicity medication, available in dosages of 1.5mg, 3mg, and 45mg, with observed mean HbATc at scheduled visits and a retrieved dropout multiple imputation (MI) based estimate at week 36. The chart shows the number of subjects with observed data at different weeks post-randomization for each dosage.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.